GRAIL, Inc. ($GRAL) Investors are Notified of the Ongoing Securities Fraud Class Action and Upcoming Deadline after Trial Results Lead to 50% Stock Drop
Bleichmar Fonti & Auld LLP issued a shareholder-solicitation notice encouraging GRAIL investors to serve as lead plaintiff in a securities fraud class action. The lawsuit alleges GRAIL misled investors regarding the NHS-Galleri trial, which failed to meet its primary endpoint in February 2026, prompting a 50.55% stock drop.
Key figures
- Stock drop percent
- 50.55%
- Stock price post drop
- $50.21
- Lead plaintiff deadline
- August 4, 2026
- Stock price prior close
- $101.53
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.